2.85
Esperion Therapeutics Inc 주식(ESPR)의 최신 뉴스
Esperion Appoints New Chief Commercial Officer - TipRanks
Esperion appoints John Harlow as chief commercial officer - Investing.com
Esperion Therapeutics Appoints New Chief Commercial Officer - TradingView
Esperion Appoints John Harlow as Chief Commercial Officer to Drive Growth and Innovation - Quiver Quantitative
Esperion Appoints Industry Veteran John Harlow as Chief Commercial Officer - The Manila Times
Esperion (NASDAQ: ESPR) appoints John Harlow CCO; led 85% revenue growth at Melinta - Stock Titan
Can Esperion Therapeutics Inc. stock double in next 5 years2025 Volatility Report & Safe Capital Preservation Plans - newser.com
Relative strength of Esperion Therapeutics Inc. in sector analysisPortfolio Risk Summary & Technical Entry and Exit Alerts - newser.com
Why retail investors favor Esperion Therapeutics Inc. stockJuly 2025 EndofMonth & Low Risk Entry Point Tips - newser.com
Smart tools for monitoring Esperion Therapeutics Inc.’s price actionBuy Signal & Safe Capital Investment Plans - newser.com
Is Esperion Therapeutics Inc. stock reversal real or fakeJuly 2025 Intraday Action & Long-Term Safe Investment Plans - newser.com
Can Esperion Therapeutics Inc. stock reach $100 price target2025 Biggest Moves & Long-Term Investment Growth Plans - newser.com
Will Esperion Therapeutics Inc. stock gain from lower inflation2025 Year in Review & Fast Exit and Entry Strategy Plans - newser.com
Will earnings trigger a reversal in Esperion Therapeutics Inc.July 2025 Update & Safe Entry Point Alerts - newser.com
Should you wait for a breakout in Esperion Therapeutics Inc.July 2025 Intraday Action & Community Consensus Trade Alerts - newser.com
How Esperion Therapeutics Inc. stock benefits from global expansion2025 Top Gainers & Technical Pattern Based Signals - newser.com
Will Esperion Therapeutics Inc. stock return to pre crisis levelsQuarterly Market Review & Real-Time Volume Trigger Notifications - newser.com
Using AI based signals to follow Esperion Therapeutics Inc.Quarterly Profit Summary & Weekly High Return Stock Forecasts - newser.com
Will Esperion Therapeutics Inc. stock outperform international peersJuly 2025 Action & Daily Volume Surge Signals - newser.com
Esperion to Participate in Jefferies Global Healthcare ConferenceLondon - The Manila Times
Esperion (NASDAQ: ESPR) to webcast Nov 18 Jefferies Global Healthcare Conference presentation - Stock Titan
Can volume confirm reversal in Esperion Therapeutics Inc.Quarterly Market Summary & High Accuracy Swing Entry Alerts - newser.com
Published on: 2025-11-03 04:49:46 - newser.com
Published on: 2025-11-03 03:31:08 - newser.com
Will Esperion Therapeutics Inc. (0ET) stock benefit from mergersMarket Sentiment Report & Technical Analysis for Trade Confirmation - newser.com
Why analysts raise outlook for Esperion Therapeutics Inc. (0ET) stockTrade Performance Summary & Target Return Focused Stock Picks - newser.com
Why Esperion Therapeutics Inc. stock is favored by top institutionsPortfolio Update Summary & AI Forecast for Swing Trade Picks - newser.com
Can Esperion Therapeutics Inc. stock deliver surprise earnings beatMarket Activity Report & Daily Profit Maximizing Trade Tips - newser.com
Published on: 2025-11-03 01:10:01 - newser.com
Why Esperion Therapeutics Inc. is moving todayJuly 2025 Retail & Capital Efficiency Focused Ideas - newser.com
How to integrate Esperion Therapeutics Inc. into portfolio analysis toolsPortfolio Gains Report & Verified Stock Trade Ideas - newser.com
How high can Esperion Therapeutics Inc. stock goPortfolio Return Summary & Real-Time Buy Signal Alerts - newser.com
Why analysts remain bullish on Esperion Therapeutics Inc. stock2025 Sector Review & Real-Time Market Sentiment Reports - newser.com
Esperion Therapeutics (NASDAQ:ESPR) Lowered to "Hold" Rating by Wall Street Zen - MarketBeat
Multi asset correlation models including Esperion Therapeutics Inc.Buy Signal & Verified Short-Term Plans - newser.com
자본화:
|
볼륨(24시간):